Objective. To evaluate work productivity and its economic burden in SSc patients.
Introduction
SSc is a chronic multi-organ autoimmune disease [1] . Women are affected up to five times more often than men and disease onset occurs mainly during peak working age (1865 years) [1, 2] . The frequency of SSc varies worldwide, with estimates of prevalence ranging from 7/ million to 489/million and incidence from 0.6/million/year to 122/million/year [3] . Australia has one of the highest reported prevalence figures [3] .
SSc is a heterogeneous disease with manifestations including skin thickening, synovitis, joint contractures, RP, digital ulceration, renal insufficiency, interstitial lung disease and pulmonary hypertension. Progressive organ involvement causes significant functional limitation leading to difficulty in employment, self-care and household chores [2, 4] . Additionally, the skin thickening caused by SSc is associated with altered physical appearance, disfigurement, pain and psychological consequences, including depression, helplessness and diminished quality of life [57] .
With long-term functional and emotional disability commencing during the working years, SSc has the potential to significantly impact employment, productivity and health-related quality of life (HRQoL). This in turn creates substantial psychosocial and economic consequences for patients, their employers and the wider society.
Work disability (WD) is a broad term used to capture work loss from complete or partial work cessation due to illness before the age of retirement [8] . Work status restriction, such as absenteeism or sick leave, and/or any reduction in productivity while present at work (presenteeism) have become recognized as important components of WD that are frequently not measured in studies [9] . Worker productivity is directly affected by illness and impacts upon workplace productivity [10] . Thus health interventions that influence worker productivity can increase workplace productivity [11] . Incorporating these components into the measurement of WD allows a more precise measurement of the workers' health status and is an important component of economic costing.
WD in SSc has never been studied in Australia; however, data from other rheumatic conditions, particularly RA, have consistently shown that functional disability and pain are associated with work impairment, particularly increased sick leave and reduced productivity [12, 13] . Outside Australia, data specific to SSc have been captured using different work ability instruments. The majority of these studies have used self-composed instruments [2, 1416] , with only a few using standard questionnaires, including the Workers' Productivity Survey (WPS) and the Work Ability Index [17, 18] . Despite differences between studies, all report a substantial prevalence of work impairment in SSc, higher than other rheumatic conditions [16] . To increase our understanding of this burden and to allow comparison between future studies, the OMERACT Worker Productivity Working Group reviewed all work ability questionnaires and recommended only two for use in rheumatological diseases, the RA-specific Work Productivity Survey (WPS-RA) and the Work Productivity and Activity Impairment (WPAI) questionnaire [19] . Patients have subsequently rated the WPAI questionnaire more favourably.
The objective of our study was to determine worker productivity, the corresponding economic burden and factors associated with reduced productivity and HRQoL in a large cohort of Australian SSc patients.
Methods

Study design and patient cohort
Consecutive patients prospectively enrolled in the Australian Scleroderma Cohort Study (ASCS), a multicentre study of risk and prognostic factors for cardiopulmonary and other clinically important outcomes in SSc, were included. Written consent was obtained from all patients at recruitment to the ASCS and for the purposes of this study, consent was assumed if patients returned the completed survey questionnaires. Ethics approval was obtained from the human research ethics committees of each of the participating hospitals.
Inclusion and exclusion criteria
We included all adult (>18 years) SSc patients from four Australian states (Victoria, Tasmania, South Australia and Western Australia) in the ASCS recruited between December 2007 and January 2016. These states were chosen since they comprise the majority of patients in the ASCS and have the most complete and up-to-date clinical data entered in the database. All patients fulfilled either the ACR or Leroy and Medsger criteria for SSc [20, 21] . After consultation with the treating physician, all living, Englishspeaking patients (n = 800) were mailed two employment questionnaires [the WPAI Questionnaire Specific Health Problem (WPAI-SHP) and a custom-made employment questionnaire] and two HRQoL questionnaires [the 36-item Short Form Health Survey (SF-36) and the PatientReported Outcomes Measurement Information System 29 (PROMIS 29)]. A cover letter explaining the purpose of the study was included in the mailed material and patients were asked to complete all of the questionnaires on the same day and return them within 6 weeks over the summer, with a specified due date.
Data collection
Questionnaire results were entered into a spreadsheet and then merged with data from the ASCS database including patient demographics, clinical variables and cardiac and pulmonary assessments. Clinical manifestations and autoantibody status were defined as present if they were present at the time of enrolment.
Outcome variables
The primary outcome variable was work productivity in SSc. We sought to determine patient and disease-related factors associated with reduced productivity and the association of work productivity with HRQoL.
WPAI-SHP outcomes
The WPAI-SHP (see supplementary data, available at Rheumatology Online) is a validated questionnaire measuring work productivity [19, 22] and is available without a fee or permission from the authors in the public domain [23] . It consists of six questions assessing the impact of a disease on work and other daily activities during the previous 7 days. Questions address employment status, number of hours missed from work due to a disease, hours missed from work for other reasons, hours actually worked, degree to which a disease affected productivity while working and the degree to which a disease affected productivity in other non-paid activities outside work. Four scores are generated, including absenteeism (work time missed), presenteeism (work impairment), work productivity loss (overall work impairment, which incorporates both absenteeism and presenteeism) and activity impairment outside work [23] . Scores are expressed as a percentage of impairment due to the disease (0100%), where a higher percentage indicates a greater reduction in productivity.
Estimation of work-related economic costs A timecost assessment using the human capital approach (HCA) was used to estimate the monetary value of the years of unemployment and productivity loss associated with SSc [24] . The HCA was chosen over the frictioncost approach (FCA) to estimate the cost associated with lost productivity, as the friction period and the costs of searching and training replacement workers were unknown, thus estimating FCA would be inexact and unreliable [25] . Furthermore, previous studies in rheumatic conditions have used the HCA to determine productivity loss, enabling comparison between studies.
Weekly and annual costs were estimated for unemployment and lost productivity from a societal perspective (55.2% of SSc patients working). Australian average weekly earnings and working hours were sourced from the Australian Bureau of Statistics (ABS).
The average Australian weekly earnings in November 2015 calculated by the ABS was AUD$1499.30 for fulltime employees and AUD$1145.60 for all employees (including both full-and part-time employees). The average Australian working week, incorporating both full-and part-time working hours, consists of 34.1 h (ABS census 2009). The annual cost from lost earnings was calculated using the average weekly wage.
Productivity loss in terms of hours of work lost per week was calculated by multiplying the average Australian weekly work hours by the percentage of total work impairment calculated from the WPAI-SHP. Annual costs were calculated by multiplying the productivity loss (in hours) by the average hourly earnings, which was calculated by dividing the average weekly earning by the average working hours per week.
We did not inquire about income on the questionnaire, as it is well recognized that self-reported income is unreliable in developed countries and can deter patients from completing the questionnaire if not compulsory [26] . Instead, we determined the socio-economic status (SES) of our SSc cohort by matching the residential postcode of each patient with the corresponding ABS Index of Relative Socioeconomic Advantage and Disadvantage (IRSAD), which incorporates variables such as income, education, occupation, housing and employment [27] . The IRSAD index was developed using data from the entire Australian population surveyed in the most recent nationwide census, which was preformed in 2011. The index summarizes the socio-economic characteristics of subjects within an area and is reported as a ranked score from 1 to 10 (10 equal deciles), with 1 representing the most disadvantaged and 10 the most advantaged areas.
Measurement of HRQoL
The SF-36 and PROMIS-29 are validated instruments for measuring HRQoL in SSc [28, 29] . The SF-36 measures eight domains of health status and provides a final score for each domain between 0 and 100, with 0 being the worst possible health and 100 the best possible health. A score >50 is better than the average US population, while a score <50 is worse. The PROMIS-29 provides a score for each health domain that is standardized against US normative population data. A score >50 is better than the average population, while a score <50 is worse. Two exceptions are for anxiety and depression, where a score >50 is worse than the general population and <50 is better.
Association of HRQoL with work productivity
We divided our patients who were working, regardless of age, into two groups, low and high productivity, based on the median productivity score. We then compared HRQoL scores in the two groups.
Statistical analysis
Data are presented as mean (S.D.) for continuous variables and as number (percentage) for categorical variables. Differences in frequency were tested using chi-square and Fisher's exact tests. Differences in continuous variables were tested using the t-test for normally distributed data and the Wilcoxon test for non-normally distributed data. Univariable and multivariable linear regression, along with post-estimation diagnostics, were used to determine the associations of different combinations of risk factors with work productivity. A two-tailed P-value 40.05 was considered statistically significant. All statistical analyses were performed using STATA 14.0 (StataCorp, College Station, TX, USA).
Results
Patient characteristics
Of 800 recipients of questionnaires, 53 (6.6%) were no longer at the last recorded address and 476 returned completed survey questionnaires, equating to a response rate of 63.7%. Only one questionnaire was returned incomplete and was not included in the data analysis. Patients who returned the questionnaires were older than patients who did not (64.2 vs 58.3 years; P < 0.001), had a longer follow-up duration from recruitment (6.4 vs 5.4 years; P < 0.001) and were more likely to have lcSSc (64.2 vs 58.3%; P < 0.001), gastrointestinal involvement (64.4 vs 55.4%; P = 0.01) and sicca symptoms (63.2 vs 55.8%; P = 0.04). There were no other statistically www.rheumatology.oxfordjournals.org significant differences between the two groups (responders and non-responders), as presented in Table 1 .
We compared patient characteristics by employment status in those <65 years of age (n = 241), as this is the standard retirement age in Australia. In those <65 years of age, 55.2% (n = 133) were employed. The unemployed patients were similar in demographic profile to those who were employed, being predominantly female (87.2%), of Caucasian ethnicity (90.7%) and with lcSSc (73.7%). Unemployed patients were older at the time of survey completion [57.1 (S.D. 6.6) vs 53.7 years (S.D. 7.9); P < 0.001], had a longer follow-up duration from recruitment (6.6 vs 6.2 years; P < 0.001) and were more likely to have synovitis, joint contractures and pulmonary arterial hypertension (P = 0.02, P = 0.04 and P < 0.001, respectively). The mean age of becoming unemployed was 48.3 years (S.D. 9.1). Disease characteristics by employment status are presented in Table 2 .
Work productivity in SSc
Of those in paid employment, 16.0% (24 of the 150 patients who responded to this question, regardless of age) reported missing work (absenteeism) in the week prior due to their health problems, accounting for 32.9% of their working week (Table 3 ). In those who reported missing work, the median number of hours missed as a consequence of SSc was 8 h [interquartile range (IQR) 212] and the number of hours missed for a cause other than SSc was 11 h (IQR 816). For all employed patients, the overall median number of hours worked in the last week was 20.5 h (IQR 1532), less than the average full-time working week (38 h) in Australia. Only 27% of patients were working 538 h/week.
Additionally, 63.3% (n = 95) reported that their working week was impaired due to their health problem (presenteeism), accounting for an average of 35.1% (S.D. 19.9) of their working week.
Overall work impairment (productivity loss), taking into account both absenteeism and presenteeism, was substantial in SSc. Two-thirds of our cohort (63.6%) reported significant overall work impairment, accounting for a mean of 38 working in the last 7 days had a greater percentage of activity impairment due to their SSc than those who were working (43.8 vs 26.5%; P < 0.001).
Factors associated with overall work impairment due to SSc, determined using univariable regression analysis, are shown in supplementary Table S1, available at Rheumatology Online. Factors associated with overall work impairment due to SSc, determined using multivariable linear regression analysis, included a lack of tertiary education (associated with 25% more work impairment; P = 0.04), synovitis (associated with 35% more work impairment; P = 0.05) and sicca symptoms (associated with 33% more work impairment; P = 0.03) ( Table 4) .
Factors associated with impairments in daily activities due to SSc, determined using univariable linear regression analysis, are shown in supplementary Table S2, available at Rheumatology Online. Factors associated with greater impairments in daily activities due to SSc, determined using multivariable linear regression analysis, included a lack of tertiary education (12% more impairment in daily activities; P = 0.04), moderatesevere interstitial lung disease (associated with 22% more impairment in daily activities; P = 0.01), digital amputation (associated with 39% more impairment in daily activities; P = 0.005) and sicca symptoms (associated with 39% more impairment in daily activities; P = 0.001) ( Table 5 ).
Work-related economic costs associated with SSc
In our cohort, 44.8% of patients <65 years old were unemployed, with an average age of 48.3 years at the time of becoming unemployed. This equates to 13.2 years of lost employment based on the average Australian retirement age of 61.5 years (2013 ABS census). Using the 2015 ABS average weekly wage, we estimated an annual cost from lost earnings of AUD$77 963.60 per patient for full-time workers or AUD$59 571.20 per patient for average earnings (incorporating both full-and part-time workers). Over the remaining working life of each unemployed ILD was diagnosed on high-resolution CT of the chest. PAH was diagnosed on right heart catheterization according to international criteria [30] . ILD: interstitial lung disease; PAH: pulmonary arterial hypertension.
a Age at unemployment according to self-report in the questionnaire. b Disease manifestations are described as present if ever present from SSc diagnosis. Gastrointestinal manifestations included the presence of any of the following: gastro-oesophageal reflux, stricture, bowel dysmotility or anal incontinence. Sicca symptoms refer to the presence of either dry eyes or mouth. Synovitis includes the presence of tender or swollen joints detected by the physician at examination. PAH is defined according to international criteria, with a mean pulmonary arterial pressure 525 mmHg and a pulmonary arterial wedge pressure 415 mmHg. ILD is defined based on abnormal high-resolution CT scan of the chest and abnormal respiratory function test. Tendon friction rub is defined as present if the physician detects it on patient examination. patient, this lost earning capacity is estimated to be AUD$1 029 119.52 per person if working full-time and AUD$786 339.84 per person for average earnings (incorporating full-and part-time workers). This cost does not include the income tax forgone or government pensions, as these figures were unobtainable at the time of this study.
For employed patients, we estimate the annual costs from lost productivity per patient from a societal perspective to be AUD$8024.20. This figure incorporate costs from both absenteeism and presenteeism, with presenteeism accounting for the majority of the cost (80.7%).
Estimation of SES in SSc patients
In our SSc cohort >70% of patients are considered to have an SES at least one decile above that of the general Australian population [median IRSAD score for the SSc cohort was 6 (IQR 49)]. We found no difference in the SES status between employed and unemployed SSc patients <65 years of age [IRSAD score for employed patients was 6.1 (IQR 2.1) vs 6.2 (2.8) for unemployed patients; P = 0.87] and no difference in the impact that SES status had on patients productivity [productivity loss for the low SES (defined as IRSAD 45) patient group was 19.3 (S.D. 23.7) while productivity loss for the high SES (defined as IRSAD 56) patient group was 25.6 (S.D. 25.9); P = 0.27]. When the low vs high productivity groups were compared, there was no difference in the IRSAD score [IRSAD score for the low productivity group was 6.9 (S.D. 2.5) vs 6.6 (3.0) for the high productivity group; P = 0.73].
Work transitions and environment modifications
In order to maintain paid employment, 42.1% (n = 56) of employed patients reported making workplace adjustments (supplementary Table S3 , available at Rheumatology Online), including reducing working hours (38.3%), changing the type of work (36.8%) and modifying their work environment (39.1%). Almost half of employed patients (48.2%) were working part time (<30 h/week), which may have been a consequence of their SSc, with more than half of the respondents who reported reduced work hours reducing their weekly hours by >15 h (supplementary Table  S3 , available at Rheumatology Online). For this reason, when calculating total cost from lost wages, we based this Variables with a P-value <0.2 and those deemed clinically significant in univariable regression analysis were included in the multivariable regression analysis.
a Disease manifestations are described as present if ever present from SSc diagnosis. Sicca symptoms refer to the presence of either dry eyes or mouth. Synovitis includes the presence of tender or swollen joints detected by the physician at examination. calculation on the average wage, which incorporated both full-and part-time workers.
Of those who were unemployed regardless of their age (n = 319), 89.0% (n = 284) had previously worked in paid employment and 45.1% (n = 144) ceased work after developing SSc. Of these previously employed patients, 35.2% (n = 100) <65 years old ceased work as a direct consequence of their SSc. Before becoming unemployed, 35.2% (n = 100) had to make alterations to their work due to SSc, including reducing working hours (30.3%), changing the type of work (27.8%) and/or modifying their work environment (28.5%) (supplementary Table S3 , available at Rheumatology Online).
For both employed and unemployed patients, hand dysfunction and RP (41.3%) were the most common reason for changing work type, followed by physical job (34.7%), lethargy (10.7%), breathlessness (6.7%) and inflexible hours (6.7%). Work environment modifications were primarily concerned with increased heating and reducing air conditioning to better manage their RP (72.7%) and modifying duties and/or getting help from co-workers, such as help with lifting (27.3%).
HRQoL in SSc patients according to work productivity
HRQoL scores were compared for patients regardless of age according to their work productivity. Patients with low productivity had significantly lower HRQoL scores across a number of SF-36 domains, including physical functioning, role physical, role emotional, vitality, social functioning, bodily pain and general health, compared with patients with higher productivity (Table 6 ). Both the mean physical and mental component scores for those with lower productivity were also significantly lower than those with higher productivity [33.4 vs 47.9 (P < 0.001) and 42.8 vs 51.1 (P < 0.001)]. These findings were mirrored in the PROMIS-29 scores (Table 6 ). The association of HRQoL and work productivity was also analysed, using work productivity as a continuous variable in both univariable and multivariable regression analysis. Lower HRQoL scores remained a significant determinant of reduced work productivity after adjusting for age, gender, disease subtype and disease severity (supplementary Table S4 , available at Rheumatology Online).
Discussion
This cross-sectional study highlights the high frequency of unemployment and reduced workplace productivity among a large cohort of Australian SSc patients. The unemployment frequency in our study was 44.8%, which is lower than that reported in the literature from France [14] , Sweden [31] , Belgium [15] and Canada [16] . It is noteworthy that our cohort is substantially larger than these (476 vs 87, 44, 84 and 61 patients, respectively) and therefore more reflective of the true employment status in the SSc population.
The lower frequency of unemployment in Australia may be due to selection bias, with patients in other studies have more clinically significant disease, or may reflect a more flexible Australian work environment empowering patients to discuss their work limitations and/or negotiate alterations in duties and hours. In our cohort, 35.9% of employed SSc patients made workplace adjustments, including reducing working hours, changing work type and modifying their work environment. However, these changes were not sufficient to maintain all patients in employment, with 31.4% of unemployed patients ceasing work as a direct consequence of their SSc, consistent with previous studies [14, 15] .
Identifying risk factors that hinder employment is important not only for raising awareness for clinicians and employers, but also for creating and implementing employment strategies and workplace modifications to enable employment to be maintained for as long as practicable. In this study, patients identified hand dysfunction and RP as the most common reasons for changing work type (41.3%), followed by a physical job (34.7%). Similarly, workplace modifications were primarily concerned with optimizing room temperature for RP management (72.7%) and modifying physical duties (27.3%). To overcome these barriers, clinicians must primarily appreciate the impact that RP and hand dysfunction can have Variables with a P-value <0.2 and those deemed clinically significant in univariable regression analysis were included in the multivariable regression analysis. b Disease manifestations are described as present if ever present from SSc diagnosis. Sicca symptoms refer to the presence of either dry eyes or mouth. Interstitial lung disease (ILD) was defined based on abnormal high-resolution CT scan of the chest and abnormal respiratory function test. Digital amputation refers to auto-or surgical amputation.
on their patients, strive to optimize medical management and recognize and refer early hand dysfunction to a hand therapist or occupational therapist. There is some evidence of improved hand function with hand occupational therapy [32] and hand surgery [33] , although careful patient selection is imperative given the potential for poor wound healing and secondary infections [33] . Additionally, educating employers about SSc and the important impact that the work environment can have on hand function and skin integrity is pivotal, as patients may not be taken seriously when these issues are raised, because of a lack of understanding of the disease. We are currently assembling a multidisciplinary team to work with patients and their employers in order to overcome these barriers.
We did not explore determinants of unemployment in this study, as we have previously identified that the presence of digital amputation [odds ratio (OR) 3.9 (95% CI 1.7, 9.1), P = 0.002], diffuse disease subtype [OR 2.2 (95% CI 1.3, 3.5), P = 0.002], sicca symptoms [OR 2.7 (95% CI 1.6, 4.4), P < 0.001], a physical job [OR 1.8 (95% CI 1.1, 3.1), P = 0.03] and pulmonary arterial hypertension [OR 2.2 (95% CI 1.1, 4.5), P = 0.02] are associated with unemployment in SSc patients [34] .
WD is one of the most important consequences of chronic rheumatic disease, impacting society through economic costs and impacting the individual through loss of income and leisure activity limitations. Economic costs consist of both direct costs, such as health carerelated costs, and indirect costs, such as lost income, productivity loss and patient and caregiver time. Estimating both of these costs is important for understanding the social impact of the disease, guiding health policy and appropriate resource allocation.
Worldwide literature confirms the high direct costs associated with SSc [3537] , however, few studies have estimated the indirect costs specifically attributable to unemployment and lost productivity. The importance of measuring indirect costs was highlighted in a large Canadian study in 2009 showing that indirect costs related to SSc are several times greater than direct costs [36] . Indirect costs related to lost productivity in that study accounted for CAD$5345, which is likely comparable to our result of AUD$8024.20 after adjusting for the time period and currency exchange.
Furthermore, until recently there was no validated instrument to measure work productivity in SSc [19] , making comparisons between studies difficult. To our knowledge there has been only one study that estimated workers' productivity in SSc using a validated questionnaire (WPS), but not economic cost [17] . Only 37% of this American cohort was employed and the average number of missed days per month was 2.6, with productivity reduced by half. The PROMIS-29 provides a score for each health domain that is standardized against US normative population data. A score >50 represents better than the general population, while a score <50 is worse than the general population. Two exceptions are for anxiety and depression, where a score >50 is worse than the general population and <50 is better.
In our cohort, of the 55.2% of patients employed, 24.4% of their total working time was impaired due to lost productivity. This equates to 8.3 h/week and 431.6 h/year of lost productivity with an associated annual cost per patient of AUD$8024.20 from a societal perspective. This highlights that despite SSc being a lowprevalence disease, it is associated with a significant economic burden without taking medical costs into consideration. In comparison with other rheumatic conditions, recognizing that these studies have different background populations, SSc patients have lower absenteeism (32.9 vs 45.5%), higher presenteeism (35.1 vs 33.3%) and lower overall work impairment (24.4 vs 29.1%) than patients with RA [38] and higher presenteeism (35.1 vs 25.0%) and lower overall work impairment (24.4 vs 33%) than patients with AS [39] .
Not only does SSc impact on working time, our study highlights its significant impact on patients' social activities, with an overall 37.9% activity limitation, which is comparable to that of RA [38] . However, treatment options in RA continue to improve, whereas SSc patients are faced with a chronic progressive course with increasing morbidity over time, without any available diseasemodifying agents or cure. It is unsurprising, therefore, to find that HRQoL is lower (higher depression and pain scores) in SSc patients than the general population and on par or lower than other chronic conditions, including other rheumatic conditions [28] . Interestingly, patients with higher work productivity in our study had better HRQoL than those with low work productivity, with lower depression, fatigue and pain scores. Depression in SSc has been reported to be associated with increased sick leave, feelings of discrimination and lack of career advancement, which may help to explain our findings [14] . However, the cross-sectional design of our study meant that we were unable to determine whether there was a causal relationship between reduced work productivity and poor HRQoL.
We recognize that there are limitations to our study. There is the potential for non-response bias between patients who did and did not complete the questionnaire; however, non-responders were younger and more likely to have dcSSc and may in fact be at higher risk of unemployment, suggesting our results may underestimate employment and productivity in SSc. Additionally, we did not use an independent measure to validate the selfreported hours, however, 95% of self-reported sick days matches registered data when the recall period is < 24 weeks [40] . Furthermore, costs were calculated using the HCA, which may overestimate costs associated with lost productivity compared with the FCA, which is increasingly being recognized as an alternative method for costing lost productivity [25, 41] . Cost calculation was based on wages for the general Australian population, which we assumed to be similar to the SSc population, as we did not have data on individual patients' incomes. Additionally, for the calculation of cost from lost productivity, we assumed that SSc patients would earn an income similar to the average weekly wage that incorporates full-and part-time employees, which may overestimate cost. Using the SES of SSc patients, we determined that the income of SSc patients is equal to if not greater than the average Australian individual's income and thus our costs may balance each of these discrepancies and in fact may be a relatively true reflection of cost. Our costs did not include lost leisure time, which may underestimate our calculation of indirect cost.
Conclusion
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